CS
BHC icon

Candriam SCA’s Bausch Health BHC Stock Holding History

Candriam SCA’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-38,961
Closed -$566K – 694
2016
Q4 		$566K Hold
38,961
– – 0.01% 600
2016
Q3 		$956K Buy
+38,961
New +$1.01M 0.02% 507
2016
Q1 		– Sell
-27,011
Closed -$2.74M – 637
2015
Q4 		$2.74M Buy
27,011
+8,768
+48% +$985K 0.07% 262
2015
Q3 		$3.25M Sell
18,243
-7,726
-30% -$1.8M 0.08% 261
2015
Q2 		$5.77M Sell
25,969
-4,607
-15% -$1.02M 0.12% 216
2015
Q1 		$6.07M Buy
30,576
+3,000
+11% +$532K 0.12% 222
2014
Q4 		$3.95M Buy
+27,576
New +$3.71M 0.08% 273

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Candriam SCA's BHC Position: Q1 2017 in Review

Candriam SCA sold out of Bausch Health (BHC) in Q1 2017, closing a stake of 38,961 shares — an estimated $566K sold.

Candriam SCA first reported a position in BHC in Q4 2014 and held it in 7 quarters. The position peaked at $6.07M in Q1 2015. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2017.

  • Candriam SCA reported no remaining Bausch Health position as of Q1 2017 after selling out during the quarter.
  • Candriam SCA sold 38,961 Bausch Health shares in Q1 2017, an estimated $566K.
  • Candriam SCA first reported a position in Bausch Health in Q4 2014 and held it in 7 quarters.
  • Candriam SCA's Bausch Health position peaked at $6.07M in Q1 2015.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2017.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.